Skip to content
Screener

Heron Therapeutics HRTX Q3 2025 earnings

Reported November 4, 2025 · Before market open

Revenue$38.2MMiss by $818.3K
EPS-$0.05Miss by $0.04
Revenue estimate$39.0M
EPS estimate-$0.01

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$37.5M
EPS estimate-$0.03

FAQ

When did Heron Therapeutics report Q3 2025 earnings?
Heron Therapeutics (HRTX) reported Q3 2025 earnings on November 4, 2025 before market open.
What were Heron Therapeutics's Q3 2025 revenue and EPS?
Heron Therapeutics reported revenue of $38.2M and eps of $-0.05 for Q3 2025.
Did Heron Therapeutics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $39.0M by $818.3K. EPS missed the consensus estimate of $-0.01 by $0.04.
How did Heron Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 9.6% from $42.3M a year earlier and eps declined 66.7% from $-0.03.
Where can I find Heron Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-263617) and the 10-Q periodic report (0001193125-25-263618) directly on SEC EDGAR. The filing index links above go to sec.gov.